Logo image of EMF

TEMPLETON EMERGING MARKETS (EMF) Stock Price, Quote, News and Overview

NYSE:EMF - New York Stock Exchange, Inc. - US8801911012 - Currency: USD

13.305  +0 (+0.04%)

Fundamental Rating

3

EMF gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. While EMF seems to be doing ok healthwise, there are quite some concerns on its profitability. EMF has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

EMF had positive earnings in the past year.
In the past year EMF had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: EMF reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: EMF reported negative operating cash flow in multiple years.
EMF Yearly Net Income VS EBIT VS OCF VS FCFEMF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

The 3 year average ROIC (1.29%) for EMF is below the current ROIC(2.24%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -15.26%
ROE -16.23%
ROIC 2.24%
ROA(3y)-4.28%
ROA(5y)0.14%
ROE(3y)-5.29%
ROE(5y)-0.32%
ROIC(3y)1.29%
ROIC(5y)1.1%
EMF Yearly ROA, ROE, ROICEMF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

EMF's Profit Margin has declined in the last couple of years.
EMF's Operating Margin has improved in the last couple of years.
In the last couple of years the Gross Margin of EMF has grown nicely.
Industry RankSector Rank
OM 65.19%
PM (TTM) N/A
GM 66.27%
OM growth 3Y19.73%
OM growth 5Y12.07%
PM growth 3Y-34.24%
PM growth 5YN/A
GM growth 3Y18.11%
GM growth 5Y10.78%
EMF Yearly Profit, Operating, Gross MarginsEMF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K -1K

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, EMF has less shares outstanding
Compared to 5 years ago, EMF has less shares outstanding
The debt/assets ratio for EMF has been reduced compared to a year ago.
EMF Yearly Shares OutstandingEMF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
EMF Yearly Total Debt VS Total AssetsEMF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

EMF has an Altman-Z score of 9.64. This indicates that EMF is financially healthy and has little risk of bankruptcy at the moment.
EMF has a debt to FCF ratio of 1.62. This is a very positive value and a sign of high solvency as it would only need 1.62 years to pay back of all of its debts.
EMF has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
Although EMF does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.62
Altman-Z 9.64
ROIC/WACCN/A
WACCN/A
EMF Yearly LT Debt VS Equity VS FCFEMF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.82 indicates that EMF may have some problems paying its short term obligations.
EMF has a Quick Ratio of 0.82. This is a bad value and indicates that EMF is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
EMF Yearly Current Assets VS Current LiabilitesEMF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

2

3. Growth

3.1 Past

EMF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 119.07%, which is quite impressive.
The earnings per share for EMF have been decreasing by -26.66% on average. This is quite bad
EMF shows a decrease in Revenue. In the last year, the revenue decreased by -1.29%.
The Revenue has been growing slightly by 4.58% on average over the past years.
EPS 1Y (TTM)119.07%
EPS 3Y-26.66%
EPS 5YN/A
EPS Q2Q%124.95%
Revenue 1Y (TTM)-1.29%
Revenue growth 3Y10.16%
Revenue growth 5Y4.58%
Sales Q2Q%-13.49%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMF Yearly Revenue VS EstimatesEMF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
EMF Yearly EPS VS EstimatesEMF Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.04, which indicates a correct valuation of EMF.
EMF is valuated cheaply when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.04
Fwd PE N/A
EMF Price Earnings VS Forward Price EarningsEMF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 32.74
EV/EBITDA N/A
EMF Per share dataEMF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.84%, EMF has a reasonable but not impressive dividend return.
Compared to an average S&P500 Dividend Yield of 2.27, EMF pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.84%

5.2 History

The dividend of EMF decreases each year by -0.03%.
EMF has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.03%
Div Incr Years0
Div Non Decr Years0
EMF Yearly Dividends per shareEMF Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of EMF are negative and hence is the payout ratio. EMF will probably not be able to sustain this dividend level.
DP-53.53%
EPS Next 2YN/A
EPS Next 3YN/A
EMF Yearly Income VS Free CF VS DividendEMF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

More info and screens

TEMPLETON EMERGING MARKETS

NYSE:EMF (2/21/2025, 8:15:40 PM)

13.305

+0 (+0.04%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners68.37%
Inst Owner Change-90.23%
Ins OwnersN/A
Ins Owner Change0%
Market Cap201.84M
Analysts0
Price TargetN/A
Short Float %0.07%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield 3.84%
Yearly Dividend1.13
Dividend Growth(5Y)-0.03%
DP-53.53%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.04
Fwd PE N/A
P/S 21.51
P/FCF 32.74
P/OCF 32.74
P/B 0.99
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)1.02
EY7.67%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.41
FCFY3.05%
OCF(TTM)0.41
OCFY3.05%
SpS0.62
BVpS13.47
TBVpS13.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.26%
ROE -16.23%
ROCE 2.84%
ROIC 2.24%
ROICexc 2.24%
ROICexgc 2.24%
OM 65.19%
PM (TTM) N/A
GM 66.27%
FCFM 65.71%
ROA(3y)-4.28%
ROA(5y)0.14%
ROE(3y)-5.29%
ROE(5y)-0.32%
ROIC(3y)1.29%
ROIC(5y)1.1%
ROICexc(3y)1.3%
ROICexc(5y)1.1%
ROICexgc(3y)1.3%
ROICexgc(5y)1.1%
ROCE(3y)1.64%
ROCE(5y)1.4%
ROICexcg growth 3Y45.26%
ROICexcg growth 5Y23.08%
ROICexc growth 3Y45.26%
ROICexc growth 5Y23.08%
OM growth 3Y19.73%
OM growth 5Y12.07%
PM growth 3Y-34.24%
PM growth 5YN/A
GM growth 3Y18.11%
GM growth 5Y10.78%
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.62
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z 9.64
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.07%
EPS 3Y-26.66%
EPS 5YN/A
EPS Q2Q%124.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.29%
Revenue growth 3Y10.16%
Revenue growth 5Y4.58%
Sales Q2Q%-13.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y255.21%
EBIT growth 3Y31.9%
EBIT growth 5Y17.2%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y109.47%
FCF growth 3Y-27.56%
FCF growth 5YN/A
OCF growth 1Y109.47%
OCF growth 3Y-27.56%
OCF growth 5YN/A